middle.news
AdAlta Raises A$1.2M to Accelerate Breakthrough CAR-T Cancer Therapy
9:14am on Tuesday 13th of January, 2026 AEDT
•
Biotechnology
Read Story
AdAlta Raises A$1.2M to Accelerate Breakthrough CAR-T Cancer Therapy
9:14am on Tuesday 13th of January, 2026 AEDT
Key Points
A$1.2 million placement at A$0.005 per share with attaching options
Funds to accelerate development of BZDS1901 CAR-T therapy for mesothelioma
Strengthens balance sheet for 'East to West' strategy leveraging Asian biotech innovation
Placement led by 62 Capital Pty Ltd with strong investor demand
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Adalta (ASX:1AD)
OPEN ARTICLE